Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.

PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All

Lloret, Alejandro, Beal, M. Flint · 2019 · Neurochemical Research

Abstract

In this review, we summarize the available published information on the neuroprotective effects of increasing nicotinamide adenine dinucleotide (NAD+) levels in Huntington's disease models. We discuss the rationale of potential therapeutic benefit of administering nicotinamide riboside (NR), a safe and effective NAD+ precursor. We discuss the agonistic effect on the Sirtuin1-PGC-1α-PPAR pathway as well as Sirtuin 3, which converge in improving mitochondrial function, decreasing ROS production and ameliorating bioenergetics deficits. Also, we discuss the potential synergistic effect of increasing NAD+ combined with PARPs inhibitors, as a clinical therapeutic option not only in HD, but other neurodegenerative conditions.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11064-019-02809-1

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 171 references

Research works printed but not linked: 1

  1. Handschin C, Rhee J, Lin J, Tarr PT, Spiegelman BM (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc Natl Acad Sci U S A 100:7111–7116 · DOI · Paper page

Cited by

See all 52

Metadata

Authors
Lloret, A., & Beal, M. F.
Affiliations
Weill Cornell Medicine (US)
Corresponding author
Lloret, Alejandro
Venue
Neurochemical Research
Published
2019-05-07
Volume
44
Issue
10
Pages
2423-2434
ISSN
  • 0364-3190 (ISSN-L)
  • 1573-6903
OpenAlex
W2944287087
Cited by
52
References
171
Citations by year
2026: 3 · 2025: 14 · 2024: 8 · 2023: 8 · 2022: 5 · 2021: 6 · 2020: 6 · 2019: 2
FWCI
0.58
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Neurochemical Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
NINDS (5R01NS086746-04)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords
Huntington's disease, NAD+, nicotinamide riboside, sirtuins, SIRT1, PGC-1α, peroxisome proliferator-activated receptors, SIRT3, PARP inhibitors, mitochondrial function, reactive oxygen species, bioenergetics, neuroprotection, neurodegenerative diseases
MeSH terms
Poly (ADP-Ribose) Polymerase-1, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Humans, Mitochondria, NAD, Neurodegenerative Diseases, Sirtuins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All. https://app.cochat.ai/papers/10.1007/s11064-019-02809-1
The paper
Lloret, A., & Beal, M. F. (2019). PGC-1α, Sirtuins and PARPs in Huntington’s Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All. Neurochemical Research. https://doi.org/10.1007/s11064-019-02809-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.